DISCONTINUED OPERATIONS

9 Months Ended

Sep. 30, 2013

Discontinued Operations [Abstract]

DISCONTINUED OPERATIONS

DISCONTINUED OPERATIONS

The Company completed the sale of OralDNA in December 2012 and completed the sale of HemoCue in April 2013. Results of operations for OralDNA, HemoCue and NID have been reported as discontinued operations for the three and nine months ended September 30, 2013 and 2012.

Discontinued operations, net of taxes, for the nine months ended September 30, 2013 includes a gain of $13.5 million (including foreign currency translation adjustments, partially offset by income tax expense and transaction costs) associated with the sale of HemoCue. In addition, income from discontinued operations, net of taxes for the nine months ended September 30, 2013, includes discrete tax benefits of $19.8 million associated with favorable resolution of certain tax contingencies related to our NID business.

Summarized financial information for the discontinued operations is set forth below:

	Three Months Ended September 30,					Nine Months Ended September 30,
	2013			2012		2013		2012
Net revenues	$	—		$	29,689	$	27,543	$	85,907
Income from discontinued operations before taxes	2,886			4,427		24,960		8,579
Income tax (expense) benefit	(480		)	114		10,537		1,437
Income from discontinued operations, net of taxes	$	2,406		$	4,541	$	35,497	$	10,016

The remaining balance sheet information related to OralDNA and NID was not material at September 30, 2013 and December 31, 2012.